Investors

Verndari is currently supported by a select group of two dozen “Angel Investors”.

Many Investors have held Senior Executive Positions in the Pharmaceutical Industry, Healthcare Industry and Banking.

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Sir John Skehel FRS FMedSci
Secretary, Biological Sciences Division, Royal Society of London

Sir John Skehel FRS FMedSci was Director of the National Institute for Medical Research (UK) from 1987 to 2006, Director of the WHO World Influenza Centre from 1975 to 1993, and currently is Secretary, Biological Sciences Division, Royal Society of London.  His research is on the structure and functions of the influenza virus hemagglutinin (HA) and neuraminidase (NA) membrane glycoproteins. He is a member of the National Academy of Sciences. 

read more